Novo Nordisk is a Denmark-based global healthcare company focused on diabetes, obesity, rare blood disorders and endocrine diseases. Its GLP-1 portfolio gives it a central position in metabolic disease treatment, with growth tied to manufacturing expansion, indication broadening, competition and reimbursement dynamics in major markets.
Advertisement
Advertisement
RNVO
Rank #4401Novo Nordisk A/S rStock
41.55
Nov 09, 20:29 UTC
Novo Nordisk A/S rStock (RNVO) Profile
About
Info & Links
Website
Contracts
- arbitrum-one:0x0e4…b0ece
- morph-l2:0x6a5…7a4bd
Read More
RNVO Statistics
24H Low/High
$40.17$41.56
- Rank#4,401
- Market Cap$307,477
- Fully Diluted Valuation$306,675
- Circulating Supply7,400
- Max Supply-
- Total Supply7,400
- 24H Trading Vol$24,771
- Hashing Algorithm-
- Block Mining Time-
Performance Table
Change vs. USD
1D
N/A
7D
+2.10%
30D
+7.51%
6M
N/A
YTD
N/A
1Y
N/A
Circulating/Total
100.00%
Mkt Dominance
0.00%
RNVO Social Stats
- Twitter Followers-
- Reddit Subscribers-
- Reddit Average Active Accounts-
- Reddit Average New Posts Per Hour-
- Reddit Average Comments Per Hour-
- Telegram Channel Users-